The impact of hypertonic saline inhalation on mucociliary clearance and nasal nitric oxide.
Nitric oxide (NO) has an influence on airway physiology by mediation in ciliary activity, inflammation, host defence, bronchial tone, and pulmonary vascular resistance. However, the clinical relevance of the measurement of nasal NO (nNO) in different physiological and pathological conditions has yet to be established before it can be used as a diagnostic tool. The aim of our study was to establish the relation between nNO and mucociliary clearance (MCC) and the impact of hypertonic saline inhalation on these markers. We examined 43 subjects. nNO was measured in the right (RnNO) and left (LnNO) nostrils before and after inhalation of hypertonic saline (HS) using a NIOX® analyser. MCC was measured before and after inhalation of HS by saccharin test. The levels of nNO before inhalation of HS (RnNO 806 ppb, IQR-337.6; LnNO 854 ppb, IQR 295.8) were significantly lower than levels after inhalation (RnNO 841.8 ppb, IQR 342.3; LnNO 897.4 ppb, IQR 304.1) (p<0.05, Wilcoxon T-test). The difference between RnNO and LnNO before and after inhalation of HS was not statistically significant. However, the difference in MCC before inhalation (507 s, IQR 233) and after inhalation of aerosol (360 s, IQR 238) was statistically significant (p<0.0001, Wilcoxon T-test). We did not confirm a correlation between nNO and MCC. An increase in osmolarity of the airway surface increases MCC and nNO, which could help to clear accumulated secretions in the airways and prevent respiratory tract infections.
Clinic of Pneumology and Phthisiology, Jessenius Faculty of Medicine, Comenius University, Martin, Slovakia. bencova.alica@gmail.com
A
A
Bencova
J
J
Vidan
E
E
Rozborilova
I
I
Kocan
D000280:Administration, Inhalation; D000328:Adult; D015415:Biomarkers / Q000378:metabolism; D001944:Breath Tests / Q000379:methods; D005260:Female; D006801:Humans; D008297:Male; D009079:Mucociliary Clearance / Q000187:drug effects / Q000502:physiology*; D009296:Nasal Cavity / Q000187:drug effects / Q000378:metabolism / Q000503:physiopathology; D009297:Nasal Mucosa / Q000378:metabolism*; D009569:Nitric Oxide / Q000378:metabolism*; D009666:Nose / Q000502:physiology*; D009994:Osmolar Concentration; D012141:Respiratory Tract Infections / Q000378:metabolism / Q000503:physiopathology; D012462:Saline Solution, Hypertonic / Q000008:administration & dosage* / Q000378:metabolism; D055815:Young Adult
D015415:Biomarkers; D012462:Saline Solution, Hypertonic; D009569:Nitric Oxide